A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1α and VEGF expression, and migration in human prostate cancer cells

MLA

Yung Hyun Choi, et al. “A Novel Resveratrol Analogue, HS-1793, Inhibits Hypoxia-Induced HIF-1α and VEGF Expression, and Migration in Human Prostate Cancer Cells.” International Journal of Oncology, vol. 43, Oct. 2013, pp. 1915–24. EBSCOhost, https://doi.org/10.3892/ijo.2013.2116.

APA

Yung Hyun Choi, Hae Young Chung, Jeong-Hyun Yoon, Nam Deuk Kim, Dong Hwan Kim, Jin-Ah Kim, Min Young Kim, Hongsuk Suh, Gi-Young Kim, & Mohammad Akbar Hossain. (2013). A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1α and VEGF expression, and migration in human prostate cancer cells. International Journal of Oncology, 43, 1915–1924. https://doi.org/10.3892/ijo.2013.2116

Chicago

Yung Hyun Choi, Hae Young Chung, Jeong-Hyun Yoon, Nam Deuk Kim, Dong Hwan Kim, Jin-Ah Kim, Min Young Kim, Hongsuk Suh, Gi-Young Kim, and Mohammad Akbar Hossain. 2013. “A Novel Resveratrol Analogue, HS-1793, Inhibits Hypoxia-Induced HIF-1α and VEGF Expression, and Migration in Human Prostate Cancer Cells.” International Journal of Oncology 43 (October): 1915–24. doi:10.3892/ijo.2013.2116.